Asclemed USA Inc., doing business as Enovachem Pharmaceuticals, has recalled approximately 107 units of Estriol, USP (Micronized) in various strengths (0.06 g, 0.12 g, and 0.24 g). This recall was initiated because laboratory testing found out-of-specification levels of impurities and degradation products. These products were distributed to six physician's offices in California between 2018 and 2019 and carry expiration dates through August 2021. Consumers should check their medication packaging for specific lot numbers to determine if their product is affected.
The presence of impurities or degradation products that exceed safety specifications can mean the medication is less effective or could potentially cause unexpected side effects or adverse reactions due to the breakdown of the active ingredient.
Return product to pharmacy for refund and consult healthcare provider.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.